SCHEMBL24259901

SCHEMBL24259901

Cc1ccc2c(c1)C(=O)N(c1ccc(Nc3ccc(N4C(=O)c5ccc(C)cc5C4=O)cc3)cc1)C2=O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.64
POLB P06746 1/20 0.64
HPGD P15428 1/20 0.64
CA9 Q16790 3/20 0.63
CA12 O43570 2/20 0.63
CA1 P00915 2/20 0.63
CA2 P00918 1/20 0.61
APP P05067 5/20 0.61
NPC1 O15118 1/20 0.61
TSHR P16473 1/20 0.61
CASP1 P29466 1/20 0.61
RAB9A P51151 1/20 0.61
CASP7 P55210 1/20 0.61
HSD17B10 Q99714 1/20 0.61
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
GFER P55789 1/20 0.57
MAPK1 P28482 1/20 0.51
ESR1 P03372 1/20 0.49
ESR2 Q92731 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16602061 0.89 CA9 (0.75) ALDH1A1POLBHPGDCA9CA12
SCHEMBL2631566 0.81 ESR1 (0.74) ALDH1A1POLBHPGDCA9CA12
SCHEMBL8604716 0.81 CA9 (0.69) ALDH1A1POLBHPGDCA9CA12
SCHEMBL30231754 0.81 CA9 (0.69) ALDH1A1POLBHPGDCA9CA12
SCHEMBL13923538 0.80 CA9 (0.63) ALDH1A1POLBHPGDCA9CA12
SCHEMBL12792336 0.80 CA9 (0.63) ALDH1A1POLBHPGDCA9CA12
SCHEMBL24642088 0.80 ALDH1A1 (0.47) ALDH1A1POLBHPGDCA9CA12
SCHEMBL14260441 0.79 CA9 (0.78) ALDH1A1POLBHPGDCA9CA12
SCHEMBL12912937 0.79 CA9 (0.78) ALDH1A1POLBHPGDCA9CA12
SCHEMBL4256256 0.79 CA9 (0.61) ALDH1A1POLBHPGDCA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11643522-B2 Polymer composition containing diarylamine-based compound ZEON CORPORATION (JP) 2023-05-09 US disclosed
EP-3590923-B1 DIARYLAMINE-BASED COMPOUND, ANTI-AGING AGENT, AND POLYMER COMPOSITION ZEON CORP (JP) 2022-08-03 EP disclosed
US-20220127430-A1 POLYMER COMPOSITION CONTAINING DIARYLAMINE-BASED COMPOUND ZEON CORPORATION (JP) 2022-04-28 US disclosed
US-11254802-B2 Diarylamine-based compound, anti-aging agent, and polymer composition ZEON CORPORATION (JP) 2022-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127430-A1 POLYMER COMPOSITION CONTAINING DIARYLAMINE-BASED COMPOUND GPX1, GPX4, GSTA1 ALDH1A1 96/4885POLB 681/4885HPGD 370/4885
US-11643522-B2 Polymer composition containing diarylamine-based compound GPX1, GPX4, GSTA1 ALDH1A1 96/4885POLB 681/4885HPGD 370/4885
US-11254802-B2 Diarylamine-based compound, anti-aging agent, and polymer composition CCNA1, CCNA2, CDKN1A ALDH1A1 539/4885POLB 283/4885HPGD 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.